rs144621796
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_033118.4(MYLK2):c.783G>A(p.Pro261Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,612,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_033118.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.783G>A | p.Pro261Pro | synonymous_variant | Exon 5 of 13 | 1 | NM_033118.4 | ENSP00000365152.4 | ||
MYLK2 | ENST00000375994.6 | c.783G>A | p.Pro261Pro | synonymous_variant | Exon 4 of 12 | 1 | ENSP00000365162.2 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152224Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000116 AC: 29AN: 249690 AF XY: 0.0000666 show subpopulations
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1460534Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 726580 show subpopulations
GnomAD4 genome AF: 0.000354 AC: 54AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74488 show subpopulations
ClinVar
Submissions by phenotype
not specified Benign:2
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Pro261Pro in exon 05 of MYLK2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.1% (4/3738) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs144621796). Pro261Pro in ex on 05 of MYLK2 (rs144621796; allele frequency = 0.1%, 4/3738) ** -
not provided Benign:2
Variant summary: The c.783G>A variant involves the alteration of a non-conserved nucleotide resulting in a synonymous change. 5/5 in silico tools via Alamut predict no significant effect on splicing.This variant is found in 14/119742 control chromosomes at a frequency of 0.0001169, which is about 5 times the maximal expected frequency of a pathogenic MYLK2 allele (0.000025). Additionally, this variant is found predominantly in Africans (11/10102; 0.00108889), which is >40-fold higher than the maximal expected allele frequency, highly suggesting this variant is benign. Furthermore, one reputable clinical diagnostic lab classifies this variant as likely benign. Taken together, this variant was classified as benign. -
This variant is associated with the following publications: (PMID: 24503780) -
Cardiomyopathy Benign:1
- -
Hypertrophic cardiomyopathy 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at